Your browser doesn't support javascript.
loading
WHO International Standard for anti-SARS-CoV-2 immunoglobulin.
Kristiansen, Paul A; Page, Mark; Bernasconi, Valentina; Mattiuzzo, Giada; Dull, Peter; Makar, Karen; Plotkin, Stanley; Knezevic, Ivana.
Affiliation
  • Kristiansen PA; Coalition for Epidemic Preparedness Innovations, Oslo, Norway.
  • Page M; National Institute for Biological Standards and Control, Potters Bar, UK.
  • Bernasconi V; Coalition for Epidemic Preparedness Innovations, Oslo, Norway.
  • Mattiuzzo G; National Institute for Biological Standards and Control, Potters Bar, UK.
  • Dull P; Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Makar K; Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Plotkin S; University of Pennsylvania, Philadelphia, PA, USA.
  • Knezevic I; WHO, Geneva 1211, Switzerland. Electronic address: knezevici@who.int.
Lancet ; 397(10282): 1347-1348, 2021 04 10.
Article in En | MEDLINE | ID: mdl-33770519

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulins / COVID-19 Vaccines / SARS-CoV-2 / Antibodies, Viral Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Lancet Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulins / COVID-19 Vaccines / SARS-CoV-2 / Antibodies, Viral Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Lancet Year: 2021 Document type: Article Affiliation country: Country of publication: